Human antibodies to human IL-6 receptor
A human antibody or an antigen-binding fragment which binds human IL-6 receptor (hIL-6R) with a K D of about 500 pM or less and blocks IL-6 activity with an IC 50 of 200 pM or less. In preferred embodiments, the antibody the antibody or antigen-binding fragment binds hIL-6R with an affinity at least 2-fold higher relative to its binding monkey IL-6R.
1. An antibody or antigen-binding fragment thereof, which specifically binds human interleukin-6 receptor (hIL-6R), comprising a heavy chain CDR1 domain comprising SEQ ID NO:149, a heavy chain CDR2 domain comprising SEQ ID NO:151, a heavy chain CDR3 domain comprising SEQ ID NO:153, a light chain CDR1 domain comprising SEQ ID NO:157, a light chain CDR2 domain comprising SEQ ID NO:159, and a light chain CDR3 domain comprising SEQ ID NO:161.
2. A pharmaceutical composition comprising the antibody or antigen-binding fragment of claim 1 and a pharmaceutically acceptable carrier.
3. The antibody or antigen-binding fragment of claim 1 , comprising a heavy chain variable region (HCVR) of SEQ ID NO:147.
4. The antibody or antigen-binding fragment of claim 1 , comprising a light chain variable region (LCVR) of SEQ ID NO:155.
5. An antibody or antigen-binding fragment thereof, which specifically binds human interleukin-6 receptor (hIL-6R), comprising a heavy chain variable region (HCVR) comprising SEQ ID NO:147, and a light chain variable region (LCVR) comprising SEQ ID NO:155.
6. A pharmaceutical composition comprising the antibody or antigen-binding fragment of claim 5 and a pharmaceutically acceptable carrier.
7. An antibody or antigen-binding fragment thereof, which specifically binds human interleukin-6 receptor (hIL-6R), wherein the antibody or antigen-binding fragment comprises a heavy and a light chain, each comprising CDR1, CDR2 and CDR3 domains, and wherein the heavy chain comprises SEQ ID NO:147 and the light chain comprises SEQ ID NO:155.
8. An antibody or antigen-binding fragment thereof, which specifically binds hIL-6R, comprising a LCVR of SEQ ID NO:155.
9. An antibody or antigen-binding fragment thereof, which specifically binds hIL-6R, comprising a HCVR of SEQ ID NO:147.